MRI, Enhanced CT, and FDG PET/CT in Basal Cell Carcinoma of the Prostate

被引：1
|
作者：
Dong, Aisheng [1 ]
Zuo, Changjing [1 ]
Lu, Jianping [2 ]
Wang, Yang [3 ]
机构：
[1] Second Mil Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Changhai Hosp, Dept Radiol, Shanghai 200433, Peoples R China
[3] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai 200433, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2014年 / 39卷 / 08期
关键词：
basal cell carcinoma; prostate cancer; prostate; MRI; CT; FDG; PET/CT;
D O I：
10.1097/RLU.0000000000000280
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Primary basal cell carcinoma of the prostate is a very rare neoplasm with a good prognosis. A 55-year-old man presented with urinary frequency for 2 months. Serum prostate-specific antigen level was normal. T2-weighted MR images showed an inhomogeneously hyperintense tumor in the prostate. Enhanced CT showed heterogeneous enhancement of the tumor. FDG PET/CT showed strong FDG uptake of the tumor with SUVmax of 14.1. Prostate biopsy findings revealed basal cell carcinoma with high proliferation index.
引用
收藏
页码：721 / 724
页数：4
相关论文
共 50 条
  • [1] Squamous Cell Carcinoma of the Prostate With Strong FDG Uptake on PET/CT
    Dong, Aisheng
    Zuo, Changjing
    Lu, Jianping
    Wang, Yang
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (07) : 650 - 652
  • [2] Widespread Metastases in Small Cell Carcinoma of the Prostate on FDG PET/CT
    Yilmaz, Mustafa
    Celen, Zeki
    Sevinc, Alper
    Karakok, Metin
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (09) : 598 - 600
  • [3] 18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
    Thacker, Curtis A.
    Weiss, Glen J.
    Tibes, Raoul
    Blaydorn, Lisa
    Downhour, Molly
    White, Erica
    Baldwin, Jason
    Von Hoff, Daniel D.
    Korn, Ronald L.
    CANCER MEDICINE, 2012, 1 (02): : 230 - 236
  • [4] Malignant Nonepithelial Prostate Tumors FDG PET/CT Findings With MRI and CT Correlation
    Dong, Aisheng
    Zhang, Huojun
    Wang, Yang
    Gong, Jing
    Zuo, Changjing
    Yang, Jijin
    Lu, Jianping
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (01) : 14 - 20
  • [5] When contrast enhanced FDG PET/CT is superior to "FDG only" enhanced PET/CT?
    Leite, Jose
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [6] Assessment of pancreatic colloid carcinoma using 18F-FDG PET/CT compared with MRI and enhanced CT
    Jiang, Lei
    Tang, Qiying
    Panje, Cedric M.
    Nie, Hongting
    Zhao, Guochao
    Shi, Hongcheng
    ONCOLOGY LETTERS, 2018, 16 (02) : 1557 - 1564
  • [7] Value of 18F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With 18F-FDG PET/CT, MRI, and Contrast-Enhanced CT
    Wang, Fei
    Guo, Rui
    Zhang, Yan
    Yu, Boqi
    Meng, Xiangxi
    Kong, Hanjing
    Yang, Yang
    Yang, Zhi
    Li, Nan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] MRI and FDG PET/CT Findings of Malignant Fibrous Histiocytoma of the Prostate
    Dong, Aisheng
    Gong, Jing
    Wang, Yang
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (10) : 889 - 891
  • [9] FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation
    Zhu, Hongjing
    Zhao, Shuai
    Zuo, Changjing
    Ren, Fangyuan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (03) : 645 - 651
  • [10] Role of diuretic enhanced FDG-PET/CT in patient with renal cell carcinoma
    Harisankar, C. N. B.
    Kamaleshwaran, K. K.
    Kashyap, R.
    Bhattacharya, A.
    Singh, B.
    Mittal, B. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S425 - S426
12345